Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

[Six-year follow-up of a patient with multiple angiomatosis involving skeleton, thoracic and abdominal cavities and the gut wall].

Adam Z, Matýšková M, Tomíška M, Rehák Z, Koukalová R, Křikavová L, Pour L, Krejčí M, Szturz P, Zahradová L, Mechl M, Moulis M, Vaníček J, Neuman C, Navrátil M, Veselý K, Hájek R, Mayer J.

Klin Onkol. 2012;25(1):47-62. Czech.

PMID:
22348220
2.

[Chronic disseminated intravascular coagulation (DIC) markers in a patient with multiple angiomatosis during treatment with anti-angiogenics: interferon α, thalidomide and lenalidomide].

Adam Z, Pour L, Matýšková M, Krejčí M, Tomíška M, Szturz P, Rehák Z, Koukalová R, Křikavová L, Nebeský T, Neuman C, Navrátil M, Hájek R, Král Z, Mayer J.

Vnitr Lek. 2012 Feb;58(2):145-53. Czech.

PMID:
22463096
3.

[Successful treatment of angiomatosis with thalidomide and interferon alpha. A description of five cases and overview of treatment of angiomatosis and proliferating hemangiomas].

Adam Z, Pour L, Krejcí M, Pourová E, Synek O, Zahradová L, Navrátil M, Mechl M, Nebeský T, Neubauer J, Feit J, Vokurková J, Král Z, Bednarík O, Slampa P, Dolezalová H, Hájek R, Mayer J.

Vnitr Lek. 2010 Aug;56(8):810-23. Review. Czech.

PMID:
20845613
4.

[Treatment of multiple angiomatosis involving the skeleton and the abdominal and thoracic cavities with interferon alpha, thalidomide and zoledronate].

Adam Z, Krikavová L, Krejcí M, Mechl M, Pour L, Moulis M, Vanícek J, Neumann C, Navrátil M, Veselý K, Vorlícek J.

Vnitr Lek. 2008 Jun;54(6):653-64. Czech.

PMID:
18672578
5.

[The effect of lenalidomide on rare blood disorders: Langerhans cell histiocytosis, multicentric Castleman disease, POEMS syndrome, Erdheim-Chester disease and angiomatosis].

Adam Z, Pour L, Krejčí M, Zahradová L, Szturz P, Koukalová R, Rehák Z, Nebeský T, Hájek R, Král Z, Mayer J.

Vnitr Lek. 2012 Nov;58(11):856-66. Review. Czech.

PMID:
23256832
7.

[Lenalidomide induced therapeutic response in a patient with aggressive multi-system Langerhans cell histiocytosis resistant to 2-chloro-deoxyadenosine and early relapsing after high-dose BEAM chemotherapy with autologous peripheral blood stem cell transplantation].

Adam Z, Rehák Z, Koukalová R, Szturz P, Krejčí M, Pour L, Zahradová L, Moulis M, Kodet R, Nebeský T, Brejcha M, Adamová Z, Hájek R, Mayer J.

Vnitr Lek. 2012 Jan;58(1):62-71. Czech.

PMID:
22448704
8.
9.

[Schnitzler syndrome--report on a fourteen-year course of the disease and an overview of information on the disease].

Adam Z, Krejcí M, Pour L, Neubauer J, Prásek J, Hájek R.

Vnitr Lek. 2008 Dec;54(12):1140-53. Review. Czech.

PMID:
19140523
10.

[Partial regression of CNS lesions of Erdheim-Chester disease after treatment with 2-chlorodeoxadenosine and their full remission following treatment with lenalidomide].

Adam Z, Sprláková A, Rehák Z, Koukalová R, Szturz P, Krejcí M, Pour L, Zahradová L, Cervinek L, Kren L, Moulis M, Hermanová M, Mechl M, Prásek J, Hájek R, Král Z, Mayer J.

Klin Onkol. 2011;24(5):367-81. Czech.

PMID:
22070019
11.

Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study.

Florakis D, Hung V, Kaltsas G, Coyte D, Jenkins PJ, Chew SL, Grossman AB, Besser GM, Monson JP.

Clin Endocrinol (Oxf). 2000 Oct;53(4):453-9.

PMID:
11012570
12.

Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk.

Van den Hout JM, Kamphoven JH, Winkel LP, Arts WF, De Klerk JB, Loonen MC, Vulto AG, Cromme-Dijkhuis A, Weisglas-Kuperus N, Hop W, Van Hirtum H, Van Diggelen OP, Boer M, Kroos MA, Van Doorn PA, Van der Voort E, Sibbles B, Van Corven EJ, Brakenhoff JP, Van Hove J, Smeitink JA, de Jong G, Reuser AJ, Van der Ploeg AT.

Pediatrics. 2004 May;113(5):e448-57.

PMID:
15121988
13.

Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.

Keam SJ, Keating GM.

Treat Respir Med. 2004;3(4):247-68. Review.

PMID:
15350163
14.
16.

[Low-dose thalidomide in refractory and relapsing multiple myeloma].

Radocha J, Maisnar V.

Vnitr Lek. 2007 Feb;53(2):129-34. Czech.

PMID:
17419173
17.

[A case of pulmonary, pleural, and renal tuberculosis associated with DIC and a prolonged increase in D-dimer].

Tojima H, Hamaoka T, Fujita A, Suzuki A.

Kekkaku. 1994 Jun;69(6):419-24. Japanese.

PMID:
8041060
18.

Significance of D-dimer concentrations during and after cardiopulmonary bypass.

Comunale ME, Carr JM, Moorman RM, Robertson LK.

J Cardiothorac Vasc Anesth. 1996 Jun;10(4):477-81.

PMID:
8776641
19.

Comparative toxicity and efficacy of combined radioimmunotherapy and antiangiogenic therapy in carcinoembryonic antigen-expressing medullary thyroid cancer xenograft.

Kraeber-Bodéré F, Bodet-Milin C, Niaudet C, Saï-Maurel C, Moreau A, Faivre-Chauvet A, Thomare P, Deleris G, Estieu-Gionnet K, Bikfalvi A, Barbet J, Paris F.

J Nucl Med. 2010 Apr;51(4):624-31. doi: 10.2967/jnumed.109.070714.

20.

Hepatic and serologic toxicity of systemic interleukin-2 and/or interferon-alpha. Evidence of a risk-benefit advantage of subcutaneous therapy.

Schomburg A, Kirchner H, Lopez-Hänninen E, Menzel T, Rudolph P, Körfer A, Fenner M, Poliwoda H, Atzpodien J.

Am J Clin Oncol. 1994 Jun;17(3):199-209.

PMID:
7910716

Supplemental Content

Support Center